Original Research ArticleInternational Surgery Journal

Publication:
Do we need group and save for trans-urethral resection of bladder tumour and trans-urethral resection of the prostate procedures?

Int Surg J. 2024;11(12):1965-1967.DOI10.18203/2349-2902.isj20243533

Read online (HTML) View on the journal's website(opens in a new tab)

Abstract

Background Trans-urethral resection of the prostate (TURP) and trans-urethral resection of bladder tumour (TURBT) are urological procedures essential for treating benign prostatic hyperplasia (BPH) and non-muscle invasive bladder cancer, respectively, these procedures may result in post-operative bleeding. In our hospital, pre-operative blood group and save is a routine to enhance patient safety. This study aims to evaluate transfusion rates and the potential cost benefits of limiting routine blood group and save.

Methods We conducted a retrospective audit of patients undergoing TURP and TURBT between October 2018 and October 2020. Data was collected using theatre system records and blood bank information regarding transfusions.

Results Out of 233 patients (average age 74), 141 underwent TURBT, 89 underwent TURP, and 3 underwent both simultaneously. Historical group and save were found in 214 (91.84%) patients, and 162 (69.5%) had same-day group and save. Only 2 patients (0.85%) necessitated transfusions.

Conclusions The necessity for blood transfusion after TURP and TURBT is low, indicating that routine pre-operative group and save may not be essential for all patients. Tailoring this practice to high-risk individuals may reduce costs and relieve workloads. Enhanced surgical techniques and tools are likely contributors to these improved outcomes.

Keywords

Affiliations

  1. Aneurin Bevan University Health Board, Newport, Wales, United Kingdom
  2. Medway NHS Trust Hospital, Kent, England, United Kingdom
  3. Swansea Bay University Health Board, Morriston, Wales, United Kingdom

Full item record